67
Views
0
CrossRef citations to date
0
Altmetric
Note

Prescription Opioid Diversion Sources Among African Americans: Implications for Overdose Prevention

References

  • Cicero, T. J., Kurtz, S. P., Surratt, H. L., Ibanez, G. E., Ellis, M. S., Levi-Minzi, M. A., & Inciardi, J. A. (2011). Multiple determinants of specific modes of prescription opioid diversion. Journal of Drug Issues, 41(2), 283–304. https://doi.org/10.1177/002204261104100207
  • Charmaz, K. (2003). Qualitative interviewing and grounded theory analysis. In J. A. Holstein and J. F. Gubrium, editors. Inside interviewing: New lenses, new concerns (pp. 311–330). Sage Publications.
  • Daniulaityte, R., Sweeney, K., Ki, S., Doebbeling, B. N., & Mendoza, N. (2022). “They say it’s fentanyl, but they honestly look like Perc 30s”: Initiation and use of counterfeit fentanyl pills. Harm Reduction Journal, 19(1), 52. https://doi.org/10.1186/s12954-022-00634-4
  • Edison, L., Erickson, A., Smith, S., Lopez, G., Hon, S., King, A., Nydam, N., O'Neal, J. P., & Drenzek, C. (2017). Notes from the field: Counterfeit Percocet-related overdose cluster – Georgia, June 2017. MMWR. Morbidity & Mortality Weekly Report, 66(41), 1119–1120. https://doi.org/10.15585/mmwr.mm6641a6
  • Hulme, S., Bright, D., & Nielsen, S. (2018). The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis. Drug & Alcohol Dependence, 186, 242–256. https://doi.org/10.1016/j.drugalcdep.2018.02.010
  • Inciardi, J. A., Surratt, H. L., Kurtz, S. P., & Cicero, T. J. (2007). Mechanisms of prescription drug diversion among drug-involved club-and street-based populations. Pain Medicine (Malden, Mass), 8(2), 171–183. https://doi.org/10.1111/j.1526-4637.2006.00255.x
  • Jones, A., Santos-Lozada, A., Perez-Brumer, A., Latkin, C., Shoptaw, S., & El-Bassel, N. (2023). Age-specific disparities in fatal drug overdoses highest among older black adults and American Indian/Alaska native individuals of all ages in the United States, 2015–2020. The International Journal on Drug Policy, 114, 103977. https://doi.org/10.1016/j.drugpo.2023.103977
  • Pletcher, M. J., Kertesz, S. G., Kohn, M. A., & Gonzales, R. (2008). Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA, 299(1), 70–78. https://doi.org/10.1001/jama.2007.64
  • Seth, P., Scholl, L., Rudd, R. A., & Bacon, S. (2018). Overdose deaths involving opioids, cocaine, and psychostimulants – United States, 2015–2016. American Journal of Transplantation, 18(6), 1556–1568. https://doi.org/10.1111/ajt.14905
  • Schuler, M. S., Schell, T. L., & Wong, E. C. (2021). Racial/ethnic differences in prescription opioid misuse and heroin use among a national sample, 1999–2018. Drug & Alcohol Dependence, 221, 108588. https://doi.org/10.1016/j.drugalcdep.2021.108588
  • Shei, A., Rice, J. B., Kirson, N. Y., Bodnar, K., Birnbaum, H. G., Holly, P., & Ben-Joseph, R. (2015). Sources of prescription opioids among diagnosed opioid abusers. Current Medical Research & Opinion, 31(4), 779–784. https://doi.org/10.1185/03007995.2015.1016607
  • Szalavitz, M., Rigg, K. K., & Wakeman, S. E. (2021). Drug dependence is not addiction – And it matters. Annals of Medicine, 53(1), 1989–1992. https://doi.org/10.1080/07853890.2021.1995623
  • Park, J. Y., & Wu, L. T. (2020). Sources of misused prescription opioids and their association with prescription opioid use disorder in the United States: Sex and age differences. Substance Use & Misuse, 55(6), 928–936. https://doi.org/10.1080/10826084.2020.1713818
  • Rigg, K. K., & Menendez, K. M. (2018). Drug prevention programmes in schools: Selecting programme providers. Health Education Journal, 77(5), 586–597. https://doi.org/10.1177/0017896918763454
  • Rigg, K. K., & Nicholson, H. L. (2019). Prescription opioid misuse among African-American adults: A rural–urban comparison of prevalence and risk. Drug & Alcohol Dependence, 197, 191–196. https://doi.org/10.1016/j.drugalcdep.2019.01.023
  • Rigg, K. K., March, S. J., & Inciardi, J. A. (2010). Prescription drug abuse and diversion: Role of the pain clinic. Journal of Drug Issues, 40(3), 681–702. https://doi.org/10.1177/002204261004000307

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.